Gastrointestinal and Other Cancers Clinical Trials

Titlesort ascending Intervention NCT ID Sponsor Status
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline NCT02134925 National Cancer Institute (NCI) Active, not recruiting
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) Placebo, Sulindac 400 MG NCT04207944 Duke University Recruiting
Testing Obeticholic Acid for Familial Adenomatous Polyposis Biopsy, Obeticholic Acid, Placebo Administration NCT05223036 National Cancer Institute (NCI) Recruiting
Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis Atorvastatin Calcium, Biopsy of Colon, Biospecimen Collection, Placebo Administration, Questionnaire Administration NCT04767984 National Cancer Institute (NCI) Recruiting
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis Placebo Administration, Questionnaire Administration, Simvastatin NCT02968810 National Cancer Institute (NCI) Active, not recruiting
Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD... Biospecimen Collection, Lisinopril, Liver Ultrasonographic Elastography, Magnetic Resonance Elastography, Magnetic Resonance Imaging, Proton Density Fat Fraction, Questionnaire Administration NCT04550481 National Cancer Institute (NCI) Recruiting
GCC Agonist Signal in the Small Intestine Biopsy, Biospecimen Collection, Esophagogastroduodenoscopy, Linaclotide, Plecanatide NCT05107219 National Cancer Institute (NCI) Recruiting
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment NCT02273362 National Cancer Institute (NCI) Active, not recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid NCT02772003 National Cancer Institute (NCI) Active, not recruiting
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration NCT03278925 National Cancer Institute (NCI) Active, not recruiting

Pages